Stay updated on FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML
Sign up to get notified when there's something new on the FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML page.

Latest updates to the FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedThe study record history shows an added revision v3.5.2 and removal of the earlier revision v3.5.0.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check39 days agoChange DetectedFooter revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision history now shows the addition of v3.4.3 and the removal of v3.4.2 in the study record history.SummaryDifference0.1%

- Check53 days agoChange DetectedVersion history shows updates to study status and location data across versions, including changes to recruitment status and site entries.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision: v3.4.2 has been added to the history, and the government funding notice and Revision: v3.4.1 have been removed.SummaryDifference0.8%

- Check82 days agoChange DetectedAdded a site-wide notice about government funding and operating status, and updated the page revision to v3.4.1. The previous revision v3.4.0 is no longer current.SummaryDifference0.8%

Stay in the know with updates to FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML
Enter your email address, and we'll notify you when there's something new on the FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML page.